St. Jude Medical (STJ) Tops Q4 EPS by 1c, FY16 EPS Guidance Falls Short

St. Jude Medical (NYSE: STJ) reported Q4 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.47 billion.

GUIDANCE:

St. Jude Medical sees Q1 2016 EPS of $0.87-$0.89, versus the consensus of $0.94.

St. Jude Medical sees FY2016 EPS of $3.95-$4.05, versus the consensus of $4.14.

• For the full-year 2016, the Company expects total sales to grow in the range of 2 percent to 4 percent

For earnings history and earnings-related data on St. Jude Medical (STJ) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79